- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03484481
Incomes of Nutritional Support Modalities in Hemodialysis Patients With Severe Malnutrition
Positive Incomes of Nutritional Support Modalities in Terms of Nutritional Status and Inflammation in Hemodialysis Patients With Severe Malnutrition
Introduction: Protein energy malnutrition is one of the strongest predictors of morbidity and mortality in maintenance hemodialysis (MHD) patients. Many reports indicate that there is a high prevalence of malnutrition up to 40% , and has a strong association with inflammation and cardiovascular disease (CVD) as well as lower quality of life in this population. The aim of this study was to compare the nutritional modalities by means of biochemical parameters, arterial stiffness and bioimpedance analysis.
Material and Methods: We designed an observational study with 56 malnourished MHD patients (mean age: 61.8±12.3 years, duration of hemodialysis: 7.9±5.1 years) . Patients were distributed into 4 groups according to patients requests for nutritional support modalities. We offered the combination of oral nutritional support (ONS) and intradialytic parenteral nutrition (IDPN) to all patients however some of the patients refused this combination thus we had 4 groups as; Group 1 (patients received only ONS and refused parenteral nutrition; n: 14), group 2 (patients received only parenteral NS and refused ONS; n: 14), group 3 (patients received both oral and parenteral NS; n: 10) and group 4 (dietetic support group; patients who refused all types of nutritional support and only followed by counselling, n: 18) for 12 months. Biochemical parameters were assessed from monthly clinical visits. Normalized protein catabolic rate (nPCR), malnutrition-inflammation score (MIS), body composition (fat mass [FM], fat-free mass (FFM) muscle mass (MM, body mass index (BMI)) by multifrequency bioimpedance analysis (BCM, Fresenius).
Study Overview
Status
Conditions
Detailed Description
Our current standard nutrition care is based upon existing recommendations and involves nutrition counselling for optimal dietary intake from food and beverages, food fortification, administration of oral nutrition supplementation (ONS) and/or IDPN in malnourished MHD patients.
Among 712 MHD patients, 138 who were diagnosed as severely malnourished (subjective global assessment (SGA) scores are B/C and serum albumin concentration <3.5 g/dL and/or a loss of ≥5% dry weight (DW) over the past 3 months ) were followed up between January 2016 - December 2016.
The patients whose at least 6 months interrupted data could be obtained under the recomemded nutritional support were included. Exclusion criteria were as follows; active infectious disease, chronic inflammatory systemic diseases (CIDs) like rheumatoid arthritis, systemic lupus erythematosus and multiple sclerosis, malabsorption syndrome, those treated with steroids or antiandrogens, inadequate dialysis (single pool Kt/V < 1.4), recent surgery within 3 months or during follow-up; hospitalization at time of randomization; nephrotic syndrome; active malignancy or history of malignancy.
eigthy-two patients were excluded according to above criteria thus 56 severely malnourished patients data was included to the study and are recommended to receive ONS and/or IDPN. The given supplementation is continued until the nutritional parameters are ameliorated. The patients choice was the determinator of the received nutritional support.
Patients were distributed into 4 groups according to patients requests for nutritional support modalities. We offered the combination of ONS and IDPN to all patients however some of the patients refused this combination thus we had 4 groups as; Group 1 (patients received only ONS and refused parenteral nutrition; n: 14), group 2 (patients received only parenteral NS and refused ONS; n: 14), group 3 (patients received both oral and parenteral NS; n: 10) and group 4 (dietetic support group; patients who refused all types of nutritional support and only followed by counselling, n: 18) (Figure 1: Study Flowchart).
All patients gave informed consent for this study, which was approved by the ethics committee of Baskent University School of Medicine.
Nutritional supplementation Each patient was consulted monthly by a dietitian to achieve the target calorie intake of 35 kcal/kg/day. A snack providing approximately 300 kcal, 14 g protein, 55 g carbohydrate, and 10 g fat was served to all patients during the sessions.
- Oral Nutrition Support (ONS): Patients in group 1 and 3 take ONS 200 ml/day twice a day at home. Each serving (200 mL) of ONS preparation (Nutrena;Abbott Nutrition, Zwolle, Holland) contained 400 kcal, 14 g protein, 41.3 g carbohydrate, and 19.2 g fat and had lower concentrations of sodium, potassium, and phosphorus than standard ONS. ONS consumption was recorded at each dialysis session.
- Intradialytic Parenteral Nutrition (IDPN) Patients in group 2 and 3 received IDPN administrations [(Kabiven central; a sterile, hypertonic emulsion, for central venous administration, in a Three Chamber Bag; the solution contains dextrose solution for fluid replenishment and caloric supply amino acid solution with electrolytes, which comprises essential and nonessential amino acids provided with electrolytes and Intralipid® 20% (a 20% Lipid Injectable Emulsion), prepared for intravenous administration as a source of calories and essential fatty acids]. Its infusion was started 30 minutes after initiation of HD via the venous port of the bubble trap on the HD tubing and continued throughout the entire HD procedure at a rate of 150 ml/h for 30 min and consisted of 300 ml for 3 hour.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- subjective global assessment (SGA) scores B or C
- serum albumin concentration <3.5 g/dL
- loss of ≥5% dry weight (DW) over the past 3 months )
Exclusion Criteria
- active infectious disease,
- chronic inflammatory systemic diseases (CIDs) like rheumatoid arthritis, systemic lupus erythematosus
- multiple sclerosis
- malabsorption syndrome
- inadequate dialysis (single pool Kt/V < 1.4)
- recent surgery within 3 months or during follow-up;
- hospitalization at time of randomization
- nephrotic syndrome
- active malignancy or history of malignancy.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
1;Oral nutritional support (ONS)
patients ongoing hemodialysis who received only oral nutritional support (Nutrena) and refused intradialytic parenteral nutrition; n: 14
|
Patients in group 1 and 3 take ONS 200 ml/day twice a day at home.
Patients in group 2 and 3 received IDPN administrations.
].
Its infusion was started 30 minutes after initiation of HD via the venous port of the bubble trap on the HD tubing and continued throughout the entire HD procedure at a rate of 150 ml/h for 30 min and consisted of 300 ml for 3 hour.
|
2; Intradialytic Parenteral Nutrition
patients ongoing hemodialysis who received only Intradialytic Parenteral Nutrition (Kabiven central) and refused parenteral nutrition; n: 14
|
|
group 3; combination group
patients ongoing hemodialysis received both ONS and Intradialytic Parenteral Nutrition NS; n: 10
|
Patients in group 1 and 3 take ONS 200 ml/day twice a day at home.
Patients in group 2 and 3 received IDPN administrations.
].
Its infusion was started 30 minutes after initiation of HD via the venous port of the bubble trap on the HD tubing and continued throughout the entire HD procedure at a rate of 150 ml/h for 30 min and consisted of 300 ml for 3 hour.
Patients in group 2 and 3 received IDPN administrations Its infusion was started 30 minutes after initiation of HD via the venous port of the bubble trap on the HD tubing and continued throughout the entire HD procedure at a rate of 150 ml/h for 30 min and consisted of 300 ml for 3 hour.
|
group 4; dietetic support group;
patients ongoing hemodialysis who refused all types of nutritional support and only followed by counselling, n: 18
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Inflammation
Time Frame: 12 months
|
C-reactive protein
|
12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3558238bc
Drug and device information, study documents
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Severe Malnutrition
-
UNICEFSave the ChildrenCompletedSevere MalnutritionCongo, The Democratic Republic of the
-
International Centre for Diarrhoeal Disease Research...UNICEFNot yet recruitingMalnutrition SevereBangladesh
-
Aga Khan UniversityAction Contre la FaimCompletedEvaluation of the Effectiveness and Impact of Community Case Management of Severe Acute MalnutritionSevere MalnutritionPakistan
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedUncomplicated Severe Acute MalnutritionBurkina Faso
-
Society for Applied StudiesWorld Health Organization; Christian Medical College, Vellore, India; ArthCompletedUncomplicated Severe Acute MalnutritionIndia
-
International Centre for Diarrhoeal Disease Research...UNICEF; NutrisetCompletedSevere Acute Malnutrition in ChildhoodBangladesh
-
University of OxfordLondon School of Hygiene and Tropical Medicine; University College, London; KEMRI-Wellcome... and other collaboratorsUnknownAntibiotic Resistance | Malnutrition Severe | Antibiotic ToxicityKenya, Uganda
-
Victor M. AguayoGandhi Medical College, Bhopal; Bundelkhand Medical College, Sagar, Madhya... and other collaboratorsCompletedSevere MalnutritionIndia
-
Institut Hospitalo-Universitaire Méditerranée InfectionCompletedMalnutrition | Child Nutrition Disorders | Kwashiorkor | Severe Malnutrition | Infant Nutrition Disorders | MarasmusNiger, Senegal
-
Liverpool School of Tropical MedicineUniversity of Toronto; Kamuzu University of Health Sciences; Queen Elizabeth...CompletedEnteritis | Severe MalnutritionMalawi
Clinical Trials on Oral Nutritional Support; Nutrena
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedMalnutrition | Retroperitoneal Sarcoma
-
Jagiellonian UniversityCompletedColon Cancer | Nutrition Aspect of CancerPoland
-
Danone Specialized Nutrition (M) Sdn BhdUniversiti Putra MalaysiaRecruiting
-
Boston Medical CenterThe International Union Against Tuberculosis and Lung DiseaseRecruiting
-
University of California, San FranciscoSan Francisco Department of Public Health; San Francisco General Hospital; Project...Completed
-
Peking Union Medical CollegeNot yet recruiting
-
University of OsloGodthaab rehabilitation centreCompleted
-
European Institute of OncologyUnknownFemale Reproductive CancerItaly
-
Ostfold Hospital TrustUniversity of OsloCompleted
-
Boston Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedProtein Feeding in Post-traumatic Injury PatientsUnited States